BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1271 related articles for article (PubMed ID: 23830918)

  • 1. Anoikis molecular pathways and its role in cancer progression.
    Paoli P; Giannoni E; Chiarugi P
    Biochim Biophys Acta; 2013 Dec; 1833(12):3481-3498. PubMed ID: 23830918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
    Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
    Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.
    Zhang P; Song Y; Sun Y; Li X; Chen L; Yang L; Xing Y
    FASEB J; 2018 Jul; 32(7):3924-3935. PubMed ID: 29505302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies.
    Zhong T; Zhang W; Guo H; Pan X; Chen X; He Q; Yang B; Ding L
    Acta Pharm Sin B; 2022 Apr; 12(4):1761-1780. PubMed ID: 35847486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids.
    Carduner L; Picot CR; Leroy-Dudal J; Blay L; Kellouche S; Carreiras F
    Exp Cell Res; 2014 Jan; 320(2):329-42. PubMed ID: 24291221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc ions as effectors of environmental oxidative lung injury.
    Wu W; Bromberg PA; Samet JM
    Free Radic Biol Med; 2013 Dec; 65():57-69. PubMed ID: 23747928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of anchorage primarily induces non-apoptotic cell death in a human mammary epithelial cell line under atypical focal adhesion kinase signaling.
    Ishikawa F; Ushida K; Mori K; Shibanuma M
    Cell Death Dis; 2015 Jan; 6(1):e1619. PubMed ID: 25611393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bibenzyl from Dendrobium ellipsophyllum inhibits epithelial-to-mesenchymal transition and sensitizes lung cancer cells to anoikis.
    Chaotham C; Pongrakhananon V; Sritularak B; Chanvorachote P
    Anticancer Res; 2014 Apr; 34(4):1931-8. PubMed ID: 24692728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The regulation of anoikis in tumor invasion and metastasis].
    Su H; Si XY; Tang WR; Luo Y
    Yi Chuan; 2013 Jan; 35(1):10-6. PubMed ID: 23357260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells.
    de Sousa Mesquita AP; de Araújo Lopes S; Pernambuco Filho PCA; Nader HB; Lopes CC
    Apoptosis; 2017 Sep; 22(9):1116-1137. PubMed ID: 28653224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals.
    Giannoni E; Fiaschi T; Ramponi G; Chiarugi P
    Oncogene; 2009 May; 28(20):2074-86. PubMed ID: 19377510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer metastases: challenges and opportunities.
    Guan X
    Acta Pharm Sin B; 2015 Sep; 5(5):402-18. PubMed ID: 26579471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular Carcinoma: Etiology and Current and Future Drugs.
    Jindal A; Thadi A; Shailubhai K
    J Clin Exp Hepatol; 2019; 9(2):221-232. PubMed ID: 31024205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
    Wu XQ; Huang C; He X; Tian YY; Zhou DX; He Y; Liu XH; Li J
    Cell Signal; 2013 Dec; 25(12):2462-8. PubMed ID: 23993966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance to EGFR tyrosine kinase inhibitors.
    Huang L; Fu L
    Acta Pharm Sin B; 2015 Sep; 5(5):390-401. PubMed ID: 26579470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition.
    Xu W; Yang Z; Lu N
    Cell Adh Migr; 2015; 9(4):317-24. PubMed ID: 26241004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.